Table 2.
Baseline patients characteristics.
| Research name | Well-developed CCC (N) | Poorly developed CCC(N) | Body mass index, kg/m2 | Hyperlipidemia, (%) | Previous myocardial infarction, (%) | LVEF, % | SYNTAX score | Position of chronic total occlusion lesion | Rentrop collateral grades | Number of diseased coronary vessels | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAD, (%) | LCX, (%) | RCA, (%) | 0, (%) | 1, (%) | 2, (%) | 3, (%) | |||||||||
| Açar et al. (15) | 131 | 163 | 27.8 | / | / | 55% | / | 41.80% | 20.10% | 38.10% | 14% | 41.50% | 27.90% | 16.70% | 1.70 |
| Balli et al. (16) | 313 | 117 | / | 49.30% | / | 46% | / | / | / | / | / | / | / | / | 1.99 |
| Baykan et al. (17) | 85 | 78 | 27.4 | 36.81% | / | / | 22.2 | 36.19% | 11.66% | 52.15% | / | / | / | / | / |
| Ceyhan et al. (18) | 67 | 46 | 26.8 | 61.06% | 51.32% | / | / | 39.82% | 24.78% | 45.13% | 2.07 | ||||
| Perera et al. (19) | 25 | 33 | / | / | 29.30% | 65% | / | 51.70% | 20.70% | 27.60% | / | / | / | / | / |
| Duyuler et al. (20) | 58 | 30 | / | / | / | 50% | / | 26.10% | 46% | 28.40% | 35.23% | 30.68% | 34.09% | / | |
| Erdoan et al. (21) | 110 | 69 | 28.6 | 74% | 16.20% | 47% | / | 45.25% | 11.18% | 40.78% | / | / | / | / | 1.2 |
| Erdoan et al. (22) | 93 | 55 | / | 75% | / | 49% | / | 49.32% | 9.46% | 42.57% | / | / | / | / | 1.2 |
| Kadi et al. (23) | 206 | 93 | / | 39.46% | / | / | / | 43.81% | 23.75% | 49.83% | / | / | / | / | 2.16 |
| Kalkan et al. (24) | 118 | 156 | 27.8 | / | / | 55% | 17.46 | 41.60% | 17.52% | 40.88% | / | / | / | / | 1.7 |
| Nacar et al. (25) | 72 | 66 | / | / | / | 45% | / | / | / | / | / | / | / | / | / |
| Sarli et al. (26) | 104 | 99 | 28 | / | / | / | / | / | / | / | 11.82% | 37.43% | 44.33% | 6.40% | / |
| Shen et al. (27) | 440 | 278 | 25.1 | 30.78% | / | / | / | / | / | / | / | / | / | / | 2.06 |
| Shen et al. (28) | 294 | 140 | 25.4 | 59.88% | / | / | / | / | / | / | / | / | / | / | 2.15 |
| Sögüt et al. (29) | 93 | 96 | 26.1 | 42.32% | / | / | / | 55.56% | 22.75% | 47.09% | / | / | / | / | 1.85 |
| Sun et al. (30) | 292 | 186 | / | 45.81 | / | / | / | / | / | / | / | / | / | / | 2.16 |
| Yang et al. (31) | 78 | 78 | 25.6 | 47.43% | / | 49% | / | / | / | / | / | / | / | / | / |
| Yang et al. (32) | 132 | 84 | 25.9 | 24% | / | 50% | / | 35% | 18% | 47% | / | / | / | / | 2.4 |